Serial Intravascular Ultrasound Analysis of Peri-Stent Remodeling and Proximal and Distal Edge Effects After Sirolimus-Eluting or Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus

American Journal of Cardiology

Volumn 103, Issue 8, 2009, Pages 1083-1088

  Jensen, Lisette Okkels ^a   Maeng, Michael ^b   Mintz, Gary S ^c   Christiansen, Evald Hoej ^b   Hansen, Knud Noerregaard ^a   Galloe, Anders ^d   Kelbaek, Henning ^e   Lassen, Jens Flensted ^b   Thuesen, Leif ^b   Thayssen, Per ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL REACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; STENT THROMBOSIS; THERAPY EFFECT;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 63749095321     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.12.035     Document Type: Article

References (30)

1. Abizaid A., Kornowski R., Mintz G.S., Hong M.K., Abizaid A.S., Mehran R., Pichard A.D., Kent K.M., Satler L.F., Wu H., Popma J.J., and Leon M.B. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 32 (1998) 584-589
2. Kornowski R., Mintz G.S., Kent K.M., Pichard A.D., Satler L.F., Bucher T.A., Hong M.K., Popma J.J., and Leon M.B. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. Circulation 95 (1997) 1366-1369
3. Mintz G.S., Nissen S.E., Anderson W.D., Bailey S.R., Erbel R., Fitzgerald P.J., Pinto F.J., Rosenfield K., Siegel R.J., Tuzcu E.M., and Yock P.G. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001) 1478-1492
4. Mintz G.S., and Weissman N.J. Intravascular ultrasound in the drug-eluting stent era. J Am Coll Cardiol 48 (2006) 421-429
5. Dibra A., Kastrati A., Mehilli J., Pache J., Schuhlen H., von B.N., Ulm K., Wessely R., Dirschinger J., and Schomig A. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
6. Hermiller J.B., Raizner A., Cannon L., Gurbel P.A., Kutcher M.A., Wong S.C., Russell M.E., Ellis S.G., Mehran R., and Stone G.W. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1172-1179
7. Sabate M., Jimenez-Quevedo P., Angiolillo D.J., Gomez-Hospital J.A., Alfonso F., Hernandez-Antolin R., Goicolea J., Banuelos C., Escaned J., Moreno R., et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial. Circulation 112 (2005) 2175-2183
8. Jensen L.O., Maeng M., Thayssen P., Christiansen E.H., Hansen K.N., Galloe A., Kelbaek H., Lassen J.F., and Thuesen L. Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial. Eur Heart J 29 (2008) 2733-2741
9. Aoki J., Mintz G.S., Weissman N.J., Mann J.I., Cannon L., Greenberg J., Grube E., Masud A.R.Z., Koglin J., Mandinov L., and Stone G.W. Chronic arterial responses to overlapping paclitaxel-eluting stents. J Am Coll Cardiol Interv 1 (2008) 161-167
10. Tanabe K., Serruys P.W., Degertekin M., Guagliumi G., Grube E., Chan C., Munzel T., Belardi J., Ruzyllo W., Bilodeau L., et al. Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial. Circulation 109 (2004) 196-200
11. Mintz G.S. Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound. Am J Cardiol 100 suppl (2007) 26M-35M
12. Serruys P.W., Degertekin M., Tanabe K., Russell M.E., Guagliumi G., Webb J., Hamburger J., Rutsch W., Kaiser C., Whitbourn R., et al. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation 109 (2004) 627-633
13. Weissman N.J., Wilensky R.L., Tanguay J.F., Bartorelli A.L., Moses J., Williams D.O., Bailey S., Martin J.L., Canos M.R., Rudra H., et al. Extent and distribution of in-stent intimal hyperplasia and edge effect in a non-radiation stent population. Am J Cardiol 88 (2001) 248-252
14. Galloe A.M., Thuesen L., Kelbaek H., Thayssen P., Rasmussen K., Hansen P.R., Bligaard N., Saunamaki K., Junker A., Aaroe J., et al. Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. JAMA 299 (2008) 409-416
15. Mintz G.S. What to do about late incomplete stent apposition?. Circulation 115 (2007) 2379-2381
16. Aoki J., Colombo A., Dudek D., Banning A.P., Drzewiecki J., Zmudka K., Schiele F., Russell M.E., Koglin J., and Serruys P.W. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 112 (2005) 3876-3883
17. Weissman N.J., Koglin J., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1201-1205
18. Ako J., Morino Y., Honda Y., Hassan A., Sonoda S., Yock P.G., Leon M.B., Moses J.W., Bonneau H.N., and Fitzgerald P.J. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 46 (2005) 1002-1005
19. Jimenez-Quevedo P., Sabate M., Angiolillo D.J., Costa M.A., Alfonso F., Gomez-Hospital J.A., Hernandez-Antolin R., Banuelos C., Goicolea J., Fernandez-Aviles F., et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial. J Am Coll Cardiol 47 (2006) 2172-2179
20. Petronio A.S., De C.M., Branchitta G., Papini B., Ciabatti N., Gistri R., Cortese B., Gherarducci G., and Barsotti A. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study. J Am Coll Cardiol 49 (2007) 539-546
21. Finn A.V., Kolodgie F.D., Harnek J., Guerrero L.J., Acampado E., Tefera K., Skorija K., Weber D.K., Gold H.K., and Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 (2005) 270-278
22. Pires N.M., Eefting D., de Vries M.R., Quax P.H., and Jukema J.W. Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries. Heart 93 (2007) 922-927
23. Cook S., Wenaweser P., Togni M., Billinger M., Morger C., Seiler C., Vogel R., Hess O., Meier B., and Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115 (2007) 2426-2434
24. Hoffmann R., Mintz G.S., Dussaillant G.R., Popma J.J., Pichard A.D., Satler L.F., Kent K.M., Griffin J., and Leon M.B. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 94 (1996) 1247-1254
25. Hong M.K., Mintz G.S., Lee C.W., Song J.M., Han K.H., Kang D.H., Song J.K., Kim J.J., Weissman N.J., Fearnot N.E., Park S.W., and Park S.J. Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT). Circulation 107 (2003) 517-520
26. Degertekin M., Serruys P.W., Tanabe K., Lee C.H., Sousa J.E., Colombo A., Morice M.C., Ligthart J.M., and de Feyter P.J. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation 108 (2003) 2747-2750
27. Hong M.K., Mintz G.S., Lee C.W., Park D.W., Park K.M., Lee B.K., Kim Y.H., Song J.M., Han K.H., Kang D.H., et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113 (2006) 414-419
28. Serruys P.W., Degertekin M., Tanabe K., Abizaid A., Sousa J.E., Colombo A., Guagliumi G., Wijns W., Lindeboom W.K., Ligthart J., de Feyter P.J., and Morice M.C. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 106 (2002) 798-803
29. Tanabe K., Serruys P.W., Degertekin M., Grube E., Guagliumi G., Urbaszek W., Bonnier J., Lablanche J.M., Siminiak T., Nordrehaug J., et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 111 (2005) 900-905
30. Mintz G.S., Shah V.M., and Weissman N.J. Regional remodeling as the cause of late stent malapposition. Circulation 107 (2003) 2660-2663